News | Neuro Imaging | January 20, 2016

MD Anderson to Study SyMRI Software for Brain Tumor Characterization

Renowned cancer center will use quantitative information from MRI enhancement software for added diagnostic value

SyMRI, MD Anderson Cancer Center, brain tumor characterization

January 20, 2016 — SyntheticMR and The University of Texas MD Anderson Cancer Center have signed a research agreement to study SyMRI to characterize brain tumors.

SyMRI provides quantitative information including tissue segmentation and T1, T2 and PD-maps, thus adding objective data to the magnetic resonance imaging (MRI) exam. The technology will be studied for its potential to add diagnostic value for various clinical applications including characterization of brain tumors.

SyMRI IMAGE generates multiple contrast images from a single 3 to 6 minute scan, thus allowing a significant reduction in scan time compared to serial acquisition of each contrast image separately. Parameters are also adjustable post-scan, enabling fine-tuning of images as well as recreation of additional contrasts. SyMRI NEURO adds quantitative data and automatic segmentation of brain tissue for efficient analysis and objective decision making.

The agreement with MD Anderson includes a one-year license of SyMRI IMAGE and SyMRI NEURO for research use at the hospital. SyMRI is CE-marked for clinical use in Europe but is not available for clinical use in the United States.

For more information: www.syntheticmr.com

Related Content

The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

Feature | ASTRO | October 20, 2018 | By Greg Freiherr
A linear accelerator combined with high-field MRI could soon be on the U.S. market. If U.S.
FDA Clears Magnetom Sola 1.5T MRI From Siemens Healthineers
Technology | Magnetic Resonance Imaging (MRI) | October 09, 2018
The U.S. Food and Drug Administration (FDA) has cleared the Magnetom Sola, a 1.5 Tesla magnetic resonance imaging (MRI...
ViewRay and Miami Cancer Institute Host Symposium on MR-Guided Radiation Therapy
News | Image Guided Radiation Therapy (IGRT) | October 05, 2018
October 5, 2018 — Leading oncology experts from around the world recently met to discuss the integration of...
An example of the newest generation of smart cardiac CT software that automatically identifies the anatomy, autotraces the centerlines on the entire coronary tree and labels each vessel segment.

An example of the newest generation of smart cardiac CT software that automatically identifies the anatomy, autotraces the centerlines on the entire coronary tree and labels each vessel segment. This greatly speeds CT workflows, saving time for techs, radiologists and cardiologists.

Feature | Radiology Imaging | October 04, 2018 | By Dave Fornell
Here is a checklist of dose-sparing practices for cardiac computed tomography (CT) imaging used in the cath lab.
Enterprise imaging has been a hot topic in radiology and healthcare information technology (IT) circles for the last several years as medical image acquisition has moved beyond the exclusive purview of radiology.
Feature | Enterprise Imaging | October 03, 2018 | By Jeff Zagoudis
Enterprise imaging has been a hot topic in radiology and healthcare information technology (IT) circles for the last...
Brainlab and Magic Leap Partner in Digital Surgery
News | Advanced Visualization | September 28, 2018
September 28, 2018 — Brainlab announced a strategic development partnership with Florida-based Magic Leap, a develope